Navigation Links
U.S. Preventive Medicine Acquires Specialty Disease Management
Date:10/2/2007

DALLAS, Oct. 2 /PRNewswire/ -- U.S. Preventive Medicine(R) (http://www.USPreventiveMedicine.com) a company organizing and commercializing the market for proactive preventive health services, announced today the acquisition of Specialty Disease Management Services, Inc., a national provider of chronic condition and health management services based in Jacksonville, Fla. Terms of the deal were not disclosed.

The addition of Specialty Disease Management's leading-edge care management programs will enable U.S. Preventive Medicine to continue the expansion of its national network of integrated services and methodologies in the areas of preventive services, health benefits and chronic and complex disease management. To meet consumers and government demand for a larger focus on preventive medicine, U.S. Preventive Medicine is building a national brand of healthcare solutions by partnering with physicians, health systems, academic medical centers, government agencies and employers.

"We believe that current outcomes can be enhanced through the implementation of clinically proven preventive and care management solutions. Specialty Disease Management has developed a unique model for disease management that complements U.S. Preventive Medicine's prevention delivery capabilities," said Brian Baum, President and COO of U.S. Preventive Medicine. "We have a strong history and working relationship with Specialty Disease Management's team in achieving successful healthcare solutions. The combination of a proven team along with the delivery of personalized preventive health and comprehensive care management will allow us to offer the highest level of value."

Specialty Disease Management Services' business model, proven in government and commercial markets, incorporates highly trained clinical staff working with patients and their physicians over the phone and in the community. Their programs include: patient and physician education; individualized care plans; clinical data gathering and analysis; and outcomes reporting. The company has been awarded numerous contracts throughout the nation and has branded several technology products to improve effectiveness and provide a competitive distinction in a quickly growing industry.

"Specialty Disease Management has proven that it can reduce health expenditures and improve clinical outcomes for people with chronic diseases -- our intent is to cover the full spectrum of care management," said Fred Goldstein, Founder, President and CEO of Specialty Disease Management. "With the national brand presence of U.S. Preventive Medicine, we can expand the scope and value of our services to a larger percent of the U.S. and international populations.

Specialty Disease Management Services contracts with employers, health plans, self insured organizations, third party administration organizations, integrated delivery organizations, physician practices and others to provide services for complex diseases that include asthma, diabetes, coronary artery disease, chronic obstructive pulmonary disease, HIV/AIDS, hypertension, heart failure, obesity, depression and schizophrenia.

By providing practical solutions at every point in the healthcare continuum of an individual's life, U.S. Preventive Medicine will have a complete toolkit to offer employers, government agencies and consumers -- regardless of where they reside. The company licenses its proprietary methodology, technology and branding assets to a health provider, which operates a local point-of-care -- The Center for Preventive Medicine(R) -- in a geographic territory on an exclusive basis. Individually, The Center for Preventive Medicine delivers a consistent suite of prevention services; collectively, Centers across the country form the U.S. Prevention Network(TM). The company also is launching The Prevention Plan(R), a groundbreaking defined health benefit for individuals and employers, set for release in 2008.

About U.S. Preventive Medicine:

U.S. Preventive Medicine(R), a privately owned company, is organizing and commercializing the market for proactive preventive health services in partnership with established hospitals and physician groups. The Company licenses its proprietary methodology, technology and branding assets to a health provider, which operates a local point-of-care -- The Center for Preventive Medicine(R) -- in a geographic territory on an exclusive basis. Individually, The Center for Preventive Medicine delivers a consistent suite of prevention services; collectively, Centers across the country form The U.S. Prevention Network.

http://www.USPreventiveMedicine.com

U.S. Preventive Medicine and/or The Center for Preventive Medicine do not themselves provide physician or professional services. All physician services are provided by independent practitioners exercising independent professional medical judgment. In addition, U.S. Preventive Medicine and/or The Center for Preventive Medicine do not interfere with or regulate the private physician- patient relationship. This document neither offers for sale nor solicits offers to purchase a franchise or investment unit in a Center for Preventive Medicine or any other security.

About Specialty Disease Management Services:

Specialty Disease Management Services delivers a unique client-based model of care coordination to improve the health of persons who suffer from chronic diseases. The company's core service, highly trained community based nurse care managers, has been developed to maximize the benefits of care coordination and to complement all aspects of disease management programs. This includes a commitment to physician-directed care, utilization of nationally recognized clinical guidelines, understanding of the social and lifestyle determinants of health and employing supportive information technology that drives measurable outcomes. Specialty Disease Management's field-based program has been applied to persons with asthma, diabetes, heart failure, HIV/AIDS, COPD, high risk pregnancy, and for persons with schizophrenia and their associated medical co-morbidities.

Specialty Disease Management was organized in 1997 by health professionals who recognized the value in coordinating care to serve people with chronic diseases. Based in Florida and contracted in six other states, Specialty Disease Management's experience offers numerous assets that are recognized for their unique contribution to disease management programs.

http://www.specialtydisease.com

Contacts:

U.S. Preventive Medicine: Kathy Fleming, USPM, 386-454-8845

or kfleming@uspreventivemedicine.com

U.S. Preventive Medicine: Aprill O. Turner, CooperKatz, 212-455-8016

or aturner@cooperkatz.com

U.S. Preventive Medicine: Nick Sowards, CooperKatz, 212-455-8008

or nsowards@cooperkatz.com


'/>"/>
SOURCE U.S. Preventive Medicine
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Onconase has Potential as Chemopreventive Agent in Mesothelioma, Reports World-Renowned Mesothelioma Researcher at AACR Annual Meeting
2. Labopharm to Present Poster on Dose Titration of Once-daily Tramadol at 3rd International Forum on Pain Medicine
3. New Proof of Genisteins Efficacy and Safety for Osteopenia and Osteoporosis Published in Annals of Internal Medicine
4. Interim Analysis of Crinone Pregnancy Study to Be Published in American Society for Reproductive Medicine Journal
5. Research on New Treatment for Neglected Disease Published in The New England Journal of Medicine
6. Data Showing that ReGens Colostrinin Supports Healthy Cognitive Function Presented at the 2007 International Congress on Natural Medicine in Australia
7. Landmark Study Published in the New England Journal of Medicine Shows Important Benefits of Eprodisate (KIACTA) Treatment for Patients with Amyloid A (AA) Amyloidosis
8. Statement by Philip Home Chairman of the RECORD Study Steering Committee and Professor of Diabetes Medicine at Newcastle University in England
9. Javelin Pharmaceuticals Phase II Rylomine (Intranasal Morphine) Data Published in Pain Medicine
10. Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data at Society Of Nuclear Medicine 2007 Annual Meeting
11. Investigation Findings, Corroborated by Empirical Evidence of the Schisandra Berry as Cardio-Tonic in Traditional Chinese Medicine for Hundreds of Years, Support the Use of Schisandrin B in the Prevention and Treatment of IHD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... -- AllianceRx Walgreens Prime, the combined central specialty pharmacy and ... manager Prime Therapeutics LLC (Prime), today officially began the ... of new signage at its headquarters in ... few other company-owned facilities across the country. This also ... whom will begin to see the AllianceRx Walgreens Prime ...
(Date:9/27/2017)... -- Commended for their devotion to personalized service, SMP Pharmacy Solutions ... in the South Florida Business Journal,s 50 Fastest-Growing Companies, and ... the national specialty pharmacy has found its niche.  To that ... be honored by SFBJ as the 2017 Power Leader in ... receive his award in October, Bardisa said of the three ...
(Date:9/22/2017)... -- As the latest Obamacare repeal effort moves is debated, ... and Lindsey Graham (R-SC) medical device market ... is in an odd place.  The industry wants repeal ... on medical device sales passed along with the Affordable ... visits and hospital customers with the funding to invest ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains to the ... save lost souls in the Philippines. “The Journey: From the Mountains to the Mission ... of the Bible. She has taught all ages and currently teaches a class of ...
(Date:10/12/2017)... ... 12, 2017 , ... CitiDent and San Francisco dentists, Dr. ... Oventus O2Vent technology. As many as 18 million Americans are estimated to suffer ... Oral appliances can offer significant relief to about 75 percent of people with ...
(Date:10/12/2017)... ... , ... IsoComforter, Inc. ( https://isocomforter.com ), one of the Nation’s ... design of the shoulder pad. The shoulder pad provides optimal support and full ... while using cold therapy. By utilizing ice and water that is circulated from an ...
(Date:10/12/2017)... ... 2017 , ... Information about the technology: , Otomagnetics has ... prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin ... cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s National ... 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. ... for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., ...
Breaking Medicine News(10 mins):